Beacon Pharmaceuticals Ltd. announced earnings results for the second quarter ended December 31, 2018. For the second quarter, the company announced sales was BDT 1,251.219 million compared to BDT 887.111 million a year ago. Operating income was BDT 109.496 million compared to BDT 65.674 million a year ago. Net income was BDT 44.575 million compared to BDT 26.346 million a year ago. Basic earnings per share was BDT 0.19 compared to BDT 0.11 a year ago. For the half year, sales was BDT 2,319.976 million compared to BDT 1,799.354 million a year ago. Operating income was BDT 167.641 million compared to BDT 138.133 million a year ago. Net income was BDT 81.729 million compared to BDT 48.806 million a year ago. Basic earnings per share was BDT 0.35 compared to BDT 0.21 a year ago.